Related references
Note: Only part of the references are listed.Protective effect of suppressor of cytokine signalling 1-based therapy in experimental abdominal aortic aneurysm
Susana Bernal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Suppressors of cytokine signaling (SOCS) proteins in inflammatory bone disorders
Mariana Rates Gonzaga Santos et al.
BONE (2020)
Early-onset autoimmunity associated with SOCS1 haploinsufficiency
Jerome Hadjadj et al.
NATURE COMMUNICATIONS (2020)
SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses
Shanzhi Huang et al.
FRONTIERS IN IMMUNOLOGY (2020)
SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19
Howard M. Johnson et al.
FRONTIERS IN IMMUNOLOGY (2020)
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes
Lucas Opazo-Rios et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Anti-inflammatory mechanisms of suppressors of cytokine signaling target ROS via NRF-2/thioredoxin induction and inflammasome activation in macrophages
Ga-Young Kim et al.
BMB REPORTS (2020)
Ligation Technologies for the Synthesis of Cyclic Peptides
Hoi Yee Chow et al.
CHEMICAL REVIEWS (2019)
SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition
Laura Lopez-Sanz et al.
LABORATORY INVESTIGATION (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
Exploring the role of unnatural amino acids in antimicrobial peptides
Rosario Oliva et al.
SCIENTIFIC REPORTS (2018)
SOCS1-based therapies mitigate vascular and renal oxidative stress in diabetic mice through STAT1-and PI3K-dependent mechanisms
L. López Sanz et al.
ATHEROSCLEROSIS (2018)
A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis
Chulbul M. Ahmed et al.
EXPERIMENTAL EYE RESEARCH (2018)
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy
Carlota Recio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors
Flavia Anna Mercurio et al.
SCIENTIFIC REPORTS (2017)
Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues
Flavia A. Mercurio et al.
CHEMBIOCHEM (2016)
Targeting Undruggable Proteins: Design of Synthetic Cyclopeptides
Anna Russo et al.
CURRENT MEDICINAL CHEMISTRY (2016)
SOCS1 mimetics and antagonists: a complementary approach to positive and negative regulation of immune function
Chulbul M. I. Ahmed et al.
FRONTIERS IN IMMUNOLOGY (2015)
Suppressor of Cytokine Signaling 1-Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice
Carlota Recio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Inhibition of IL-6 family cytokines by SOCS3
Jeffrey J. Babon et al.
SEMINARS IN IMMUNOLOGY (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Suppression of cytokine signaling: The SOCS perspective
Edmond M. Linossi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses
Stefania Madonna et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Aromatic interactions with naphthylalanine in a β-hairpin peptide
Daniel Meyer et al.
JOURNAL OF PEPTIDE SCIENCE (2013)
New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries
Nunzianna Doti et al.
BIOCHEMICAL JOURNAL (2012)
Suppressors of Cytokine Signaling (SOCS) Proteins and JAK/STAT Pathways Regulation of T-Cell Inflammation by SOCS1 and SOCS3
Taiga Tamiya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Definition and testing of the GROMOS force-field versions 54A7 and 54B7
Nathan Schmid et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2011)
An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0
Alpeshkumar K. Malde et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Israel F. Charo et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation, and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease
Enza Lonardo et al.
STEM CELLS (2010)
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Neal K. Williams et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Past and Future Perspectives of Synthetic Peptide Libraries
Daniela Marasco et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
Suppressor of cytokine signaling 1 inhibits IFN-γ inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation
Stefania Madonna et al.
FASEB JOURNAL (2008)
Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1
Salvatore Ponticelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SOCS regulation of the JAK/STAT signalling pathway
Ben A. Croker et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Interferon-γ-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis
Roumen Balabanov et al.
JOURNAL OF NEUROSCIENCE (2007)
SOCS proteins, cytokine signalling and immune regulation
Akihiko Yoshimura et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity
JE Fenner et al.
NATURE IMMUNOLOGY (2006)
SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential
GM Davey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulation of the immune system by SOCS family adaptor proteins
S Ilangumaran et al.
SEMINARS IN IMMUNOLOGY (2004)
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse
WS Alexander et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1)
F Giordanetto et al.
PROTEIN ENGINEERING (2003)
Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1
JL Eyles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation
DL Krebs et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA
T Herrmann et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Share Paper
